{"database": "openregs", "table": "documents", "rows": [["FDA-2020-D-1138-0127", "FDA", "FDA-2020-D-1138", "Enforcement Policy for Modifications to FDA-Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency Guidance for Industry and Food and Drug Administration Staff", "Other", "Guidance", "2020-10-13T04:00:00Z", 2020, 10, "2020-10-14T04:00:00Z", "2023-11-08T04:59:59Z", "2023-05-24T21:11:40Z", null, 0, 0, "090000648490a841"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2020-D-1138-0127"], "units": {}, "query_ms": 69.74168797023594, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}